Dr. Scott L Tashman, PhD
Claim this profileStudies Osteoarthritis
Studies Osteoarthritis Treatment Costs
1 reported clinical trial
2 drugs studied
More about Scott L Tashman, PhD
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Scott L Tashman, PhD has experience with
- Fisetin
- Losartan
Breakdown of trials Scott L Tashman, PhD has run
Osteoarthritis
Osteoarthritis Treatment Costs
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott L Tashman, PhD specialize in?
Scott L Tashman, PhD focuses on Osteoarthritis and Osteoarthritis Treatment Costs. In particular, much of their work with Osteoarthritis has involved treating patients, or patients who are undergoing treatment.
Is Scott L Tashman, PhD currently recruiting for clinical trials?
No, Scott L Tashman, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Scott L Tashman, PhD has studied deeply?
Yes, Scott L Tashman, PhD has studied treatments such as Fisetin, Losartan.
What is the best way to schedule an appointment with Scott L Tashman, PhD?
Apply for one of the trials that Scott L Tashman, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.